|
Name |
1,3-Dihydroxy-8-methoxy-6-methylanthracene-9,10-dione
|
Molecular Formula | C16H12O5 | |
IUPAC Name* |
1,3-dihydroxy-8-methoxy-6-methylanthracene-9,10-dione
|
|
SMILES |
CC1=CC2=C(C(=C1)OC)C(=O)C3=C(C2=O)C=C(C=C3O)O
|
|
InChI |
InChI=1S/C16H12O5/c1-7-3-9-14(12(4-7)21-2)16(20)13-10(15(9)19)5-8(17)6-11(13)18/h3-6,17-18H,1-2H3
|
|
InChIKey |
IKIAXVIGUJMLHC-UHFFFAOYSA-N
|
|
Synonyms |
1-O-Methylemodin; 3775-08-4; 1,3-Dihydroxy-8-methoxy-6-methylanthracene-9,10-dione; O-methylemodin; 1-METHYL EMODIN; CHEMBL453316; SCHEMBL16225819; 1,3-dihydroxy-8-methoxy-6-methyl-anthracene-9,10-dione; 9,10-Anthracenedione, 1,3-dihydroxy-8-methoxy-6-methyl-; DTXSID30440475; 6,8-Dihydroxy-1-methoxy-3-methylanthraquinone; D85146
|
|
CAS | 3775-08-4 | |
PubChem CID | 10469084 | |
ChEMBL ID | CHEMBL453316 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 284.26 | ALogp: | 3.0 |
HBD: | 2 | HBA: | 5 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 83.8 | Aromatic Rings: | 3 |
Heavy Atoms: | 21 | QED Weighted: | 0.717 |
Caco-2 Permeability: | -5.002 | MDCK Permeability: | 0.00001470 |
Pgp-inhibitor: | 0.021 | Pgp-substrate: | 0.009 |
Human Intestinal Absorption (HIA): | 0.028 | 20% Bioavailability (F20%): | 0.054 |
30% Bioavailability (F30%): | 0.993 |
Blood-Brain-Barrier Penetration (BBB): | 0.063 | Plasma Protein Binding (PPB): | 97.34% |
Volume Distribution (VD): | 0.494 | Fu: | 1.96% |
CYP1A2-inhibitor: | 0.953 | CYP1A2-substrate: | 0.848 |
CYP2C19-inhibitor: | 0.157 | CYP2C19-substrate: | 0.063 |
CYP2C9-inhibitor: | 0.571 | CYP2C9-substrate: | 0.632 |
CYP2D6-inhibitor: | 0.417 | CYP2D6-substrate: | 0.264 |
CYP3A4-inhibitor: | 0.696 | CYP3A4-substrate: | 0.157 |
Clearance (CL): | 10.801 | Half-life (T1/2): | 0.353 |
hERG Blockers: | 0.028 | Human Hepatotoxicity (H-HT): | 0.05 |
Drug-inuced Liver Injury (DILI): | 0.917 | AMES Toxicity: | 0.817 |
Rat Oral Acute Toxicity: | 0.176 | Maximum Recommended Daily Dose: | 0.92 |
Skin Sensitization: | 0.22 | Carcinogencity: | 0.26 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.961 |
Respiratory Toxicity: | 0.103 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000939 | 0.932 | D07MGA | 0.388 | ||||
ENC001971 | 0.773 | D0N1FS | 0.354 | ||||
ENC005602 | 0.773 | D06GCK | 0.326 | ||||
ENC000094 | 0.762 | D04AIT | 0.307 | ||||
ENC000913 | 0.746 | D0AZ8C | 0.303 | ||||
ENC005489 | 0.743 | D0K8KX | 0.300 | ||||
ENC002107 | 0.731 | D01XWG | 0.280 | ||||
ENC000362 | 0.727 | D07VLY | 0.273 | ||||
ENC003915 | 0.689 | D0C9XJ | 0.273 | ||||
ENC002766 | 0.681 | D01XDL | 0.250 |